Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 964.00
-31.15 (-3.13%)
Jul 31, 2025, 3:29 PM IST
Zydus Lifesciences Employees
Zydus Lifesciences had 27,917 employees as of March 31, 2025. The number of employees increased by 996 or 3.70% compared to the previous year.
Employees
27,917
Change (1Y)
996
Growth (1Y)
3.70%
Revenue / Employee
$8,325,214
Profits / Employee
$1,621,055
Market Cap
975.85B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27,917 | 996 | 3.70% |
| Mar 31, 2024 | 26,921 | 3,895 | 16.92% |
| Mar 31, 2023 | 23,026 | -717 | -3.02% |
| Mar 31, 2022 | 23,743 | -669 | -2.74% |
| Mar 31, 2021 | 24,412 | -588 | -2.35% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 10,542 |
| Cipla | 30,313 |
| Apollo Hospitals Enterprise | 83,147 |
| Mankind Pharma | 26,978 |
| Aurobindo Pharma | 26,015 |
| Fortis Healthcare | 12,237 |
| Glenmark Pharmaceuticals | 14,989 |
Zydus Lifesciences News
- 7 days ago - Zydus Lifesciences gets tentative approval from USFDA for Ibrutinib tablets - Business Upturn
- 16 days ago - Zydus Lifesciences secures USFDA approval for Celecoxib Capsules - Business Upturn
- 23 days ago - Jefferies maintains buy on Zydus Lifesciences, sees 15.5% upside on resilient FY26 growth outlook - Business Upturn
- 6 weeks ago - Zydus completes USFDA inspection at oncology plant with two minor observations, none related to data integrity - Business Upturn
- 7 weeks ago - Stocks to watch on June 12: Zydus Life, Adani Group, Tanla Platforms, HUL, Nazara Tech, MCX in focus - Business Upturn
- 7 weeks ago - Zydus receives USFDA EIR for Ankleshwar API facility with ‘No Action Indicated’ status - Business Upturn
- 7 weeks ago - Zydus receives EIR with VAI classification from USFDA for Dabhasa API facility - Business Upturn
- 2 months ago - Top stocks to buy today: Stock recommendations for June 5, 2025 - The Times of India